Apollo Cancer Centres and Accuray launch India’s first Robotic Radiotherapy program

New Delhi: Apollo Cancer Centres (ACC), in collaboration with Accuray has announced the launch of the first Robotic and Stereotactic Therapy Education Centre in the Indian Subcontinent.

The new Robotic & Stereotactic Radiosurgery program will be established at ACC facilities in Chennai and Bangalore, providing advanced radiosurgery training to radiation oncologists, physicists, radiation therapists, and technologists from India and surrounding regions. 

The establishment of this educational center will significantly enhance the development of oncology care in the region. This program will offer comprehensive discussions, demonstrations, and hands-on training focused on robotic and stereotactic radiosurgery. It represents a significant advancement in India’s medical education landscape, providing world-class training locally. Participants will benefit from in-depth discussions and practical learning experiences.

Dinesh Madhavan, President of Group Oncology and International at Apollo Hospital Enterprises Ltd, remarked, “In the field of cancer care ground-breaking technologies pave the way for highly personalized and effective treatment. The inception of the Robotic Stereotactic Radiotherapy Program by Apollo Cancer Centres and Accuray will advance training facilities for the ASEAN region. It will help equip oncologists, physicists, and therapists with the critical knowledge and skills needed to leverage the latest in CyberKnife technology. ”

Dr. Sridhar PS, Lead of CyberKnife – Robotic Radiosurgery, highlighted, “The launch of the training program at Apollo Cancer Centre is an exceptional opportunity to enhance skills and knowledge in Robotic & Stereotactic Radiotherapy. Since pioneering the Cyberknife Robotic Radio Surgery System in India and a rich experience of over 5000 patients, we will now share valuable knowledge in the training program. It will enable oncologists in the development of Cancer care through Cyberknife training.”

Suzanne Winter, President & CEO of Accuray, expressed, “Accuray celebrates the expansion of the CyberKnife® S7TM System to Apollo centers in Chennai and Bangalore, showcasing our enduring collaboration with Apollo Hospitals to enhance cancer care in India. With its unparalleled precision, the CyberKnife S7 System redefines treatment standards, empowering clinicians to optimize outcomes. Additionally, it enables the delivery of high doses of radiation, typically in 1 to 5 sessions for fast and effective treatments, marking a significant advancement in cancer therapy.”

The CyberKnife System is a non-invasive, robotic radiation therapy device designed to treat tumors with high precision while minimizing damage to surrounding healthy tissue. It uses advanced imaging and computerized robotics to deliver highly focused beams of radiation, allowing for the treatment of complex and hard-to-reach tumors.